NFE2L2 and metastatic neoplasm: To evaluate NRF2 expression in primary and metastatic tumors, we examined NRF2 expression in 51 patients by immunohistochemistry and found that NRF2 levels were significantly higher in the metastasis tumor group than in the normal ovary group (Fig. 1A).